A newborn presenting with epidermolysis bullosa with duodenal atresia: A very rare case report and review of the literature

Document Type: Case Report


1 Department of Pediatrics, Mahatama Gandhi Institute of Medical and Sciences, Jaipur, Rajasthan, India

2 Department of Neonatology, Fernandez Hospital, Hyderguda, Hyderabad, Andhra- Pradesh, India

3 Department of Radiology, Indian Diagnostic Center New Delhi, India


Background: Epidermolysis bullosa (EB) comprises a group of genetically determined skin fragility disorders, which are characterized by blistering of the skin and mucosa, in response to little or no apparent trauma. These disorders represent heterogeneous phenotypes and are associated with various complications ranging from localized skin fragility to neonatal death. Nevertheless, the term "Epidermolysis" is a misnomer as epidermal disruption is not the principal alteration in two of the primary types of EB. In clinical, laboratory and epidemiological studies, this complex and heterogeneous group of disorders is classified, on the basis of the mode of inheritance, into three major types: EB simplex (EBS), junctional EB (JEB) and dystrophic EB (DEB). EB is a rare disease with an incidence rate of approximately 50 in 1 million live births, and 9 in 1 million people in the world population. Of these cases, about 92% are EBS, 5% are DEB, 1% is JEB and 2% are unclassified (1).
Case presentation: In this study, we presented the case of a male newborn with EB and concomitant pyloric stenosis. To the best of our knowledge, only one case of this rare combination of EB with duodenal atresia has been retrieved in PubMed.


  1. Fine JD, Johnson LB, Suchindran C, Moshell A, Gedde-Dahl T. The Epidemiology of Inherited Epidermolysis Bulllosa: Findings in the US, Canadian and European Study Populations. In: Fine JD, Bauer EA, Mc Guire J, Moshell A, editors. Clinical, Epidemiological and Laboratory Advances and the Findings of the National Epidermolysis Bullosa Registry. 1st ed. Baltimore: The Johns Hopkins University Press; 1999. P.101-13.
  2. Briggaman RA. Hereditary epidermolysis bullosa with special emphasis on newly recognized syndromes and complications. Dermatol Clin. 1983; 1:263-80.
  3. Solovan C, Ciolan M, Olariu L. The biomolecular and ultrastructural basis of epidermolysis bullosa. Acta Dermatovenerol Alp Pannonic Adriat. 2005; 14(4):127-35.
  4. Honig PJ, Yoder M, Ziegler M. Acquired pyloric obstruction in a patient with epidermolysis bullosa letalis. J Pediatr. 1983; 102(4):598-600.
  5. Morrell DS, Fine JD. Junctional epidermolysis bullosa with pyloric stenosis. Pediatr Dermatol. 2001; 18(6):539-40.
  6. Pulkkinen L, Kimonis VE, Xu Y, Spanou EN, McLean WH, Uitto J. Homozygous alpha6 integrin mutation in junctional epidermolysis bullosa with congenital duodenal atresia. Hum Mol Genet. 1997; 6(5):669-74.
  7. Bailey PV, Tracy TF Jr, Connors RH, Mooney DP, Lewis JE, Weber TR. Congenital duodenal obstruction: a 32-year review. J Pediatr Surg. 1993; 28(1):92-5.
  8. Brown TA, Gil SG, Sybert VP, Lestringant GG, Tadini G, Caputo R, et al. Defective integrin alpha 6 beta 4 expression in the skin of patients with junctional epidermolysis bullosa and pyloric atresia. J Invest Dermatol. 1996; 107(3):384-91.
  9. Butler DF, Berger TG, James WD, Smith TL, Stanely JR, Rodman OG. Bart's syndrome: microscopic, ultrastructural, and immunofluorescent mapping features. Pediatr Dermatol. 1986; 3(2):113–8.
  10. Samad L, Siddiqui EF, Arain MA, Atif M, Parkash J, Ahmed S, et al. Pyloric atresia associated with epidermolysis bullosa--three cases presenting in three months. J Pediatr Surg. 2004; 39(8):1267–9.
11. Hünefeld C, Mezger M, Kern JS, Nyström A, Bruckner-Tuderman L, Müller I, et al. One goal, different strategies--molecular and cellular approaches for the treatment of inherited skin fragility disorders. Exp Dermatol. 2013; 22(3):162-7.

12. Dank JP, Kim S, Parisi MA, Brown T, Smith LT, Waldhausen J, et al. Outcome after surgical repair of junctional epidermolysis bullosa-pyloric atresia syndrome: a report of 3 cases and review of the literature. Arch Dermatol. 1999; 135(10):1243–7.